Contrast is the relative difference of signal intensities in two adjacent regions of an image.
Due to the T1 and T2 relaxation properties in magnetic resonance imaging, differentiation between various tissues in the body is possible. Tissue contrast is affected by not only the T1 and T2 values of specific tissues, but also the differences in the magnetic field strength, temperature changes, and many other factors. Good tissue contrast relies on optimal selection of appropriate pulse sequences (spin echo, inversion recovery, gradient echo, turbo sequences and slice profile).
Important pulse sequence parameters are TR (repetition time), TE (time to echo or echo time), TI (time for inversion or inversion time) and flip angle. They are associated with such parameters as proton density and T1 or T2 relaxation times. The values of these parameters are influenced differently by different tissues and by healthy and diseased sections of the same tissue.
For the T1 weighting it is important to select a correct TR or TI. T2 weighted images depend on a correct choice of the TE. Tissues vary in their T1 and T2 times, which are manipulated in MRI by selection of TR, TI, and TE, respectively. Flip angles mainly affect the strength of the signal measured, but also affect the TR/TI/TE parameters.
Conditions necessary to produce different weighted images:
T1 Weighted Image: TR value equal or less than the tissue specific T1 time - TE value less than the tissue specific T2 time.
T2 Weighted Image: TR value much greater than the tissue specific T1 time - TE value greater or equal than the tissue specific T2 time.
Proton Density Weighted Image: TR value much greater than the tissue specific T1 time - TE value less than the tissue specific T2 time.

See also Image Contrast Characteristics, Contrast Reversal, Contrast Resolution, and Contrast to Noise Ratio.

'CMC Contrast AB (Copenhagen Malmø Contrast AB) was established in April 2000. CMC Contrast AB was founded by professor Henrik Thomsen and the two main owners Malmøhus Invest AB and Öresund - Healthcare Capital KS.'
'The purpose of CMC Contrast AB is to develop the product CMC 001 to a registered medicinal product with market authorisation in the international pharmaceutical markets. CMC Contrast AB holds all the rights to CMC 001, and the company aims to develop CMC 001 to a registered medicinal product on a worldwide basis.'

Contrast agents are chemical substances introduced to the anatomical or functional region being imaged, to increase the differences between different tissues or between normal and abnormal tissue, by altering the relaxation times. MRI contrast agents are classified by the different changes in relaxation times after their injection.
The design objectives for the next generation of MR contrast agents will likely focus on prolonging intravascular retention, improving tissue targeting, and accessing new contrast mechanisms. Macromolecular paramagnetic contrast agents are being tested worldwide. Preclinical data shows that these agents demonstrate great promise for improving the quality of MR angiography, and in quantificating capillary permeability and myocardial perfusion.
Ultrasmall superparamagnetic iron oxide (USPIO) particles have been evaluated in multicenter clinical trials for lymph node MR imaging and MR angiography, with the clinical impact under discussion. In addition, a wide variety of vector and carrier molecules, including antibodies, peptides, proteins, polysaccharides, liposomes, and cells have been developed to deliver magnetic labels to specific sites. Technical advances in MR imaging will further increase the efficacy and necessity of tissue-specific MRI contrast agents.

See also Adverse Reaction and Nephrogenic Systemic Fibrosis.

See also the related poll result: 'The development of contrast agents in MRI is'

A contrast medium (or contrast agent) is a chemical substance introduced to the anatomical or functional region being imaged, to increase the differences between different tissues or between normal and abnormal tissue, by altering the relaxation times.
The chemical composition of the contrast media determines the specific usage. Similar to nuclear imaging is the intention in development of MR contrast media a high affinity to different organs or even tumors (e.g. necrosis avid contrast agent).
In 'contrast' to nuclear imaging contrast agents MR contrast media do not contain radiopharmaceuticals and the concentrations are about 100 times higher. Nuclear imaging contrast agents are direct contrast agents;; they are directly visible caused by their radioactivity. MR contrast agents affect the targeted tissue; they are indirect contrast agents.
See also Contrast Agents, the info sheet gives an overview and more in-depth information about different types of MRI contrast medium.

Contrast reversal is an MR image phenomenon where the dark parts become bright, and the bright parts become dark. This is usually most prevalent in sequences utilizing an extended TR.